Latest News for: angitia

Edit

Angitia Biopharmaceuticals Presents Data from Phase 1/2 Study of AGA111 at 2025 AAOS Annual Meeting

Nasdaq Globe Newswire 18 Mar 2025
AGA111 treatment resulted in high spinal fusion success rate and improved functional outcomes. AGA111 treatment resulted in high spinal fusion success rate and improved functional outcomes ... .
  • 1
×